These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5923164)

  • 1. Action of 1-beta-D-arabinofuranosyl-5-fluorocytosine on the nucleic acid metabolism and viability of HeLa cells.
    Kim JH; Eidinoff ML; Fox JJ
    Cancer Res; 1966 Aug; 26(8):1661-4. PubMed ID: 5923164
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds.
    Renis HE
    Cancer Res; 1970 Jan; 30(1):189-94. PubMed ID: 5466741
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.
    Graham FL; Whitmore GF
    Cancer Res; 1970 Nov; 30(11):2627-35. PubMed ID: 5530557
    [No Abstract]   [Full Text] [Related]  

  • 4. Nucleoside analogues as antiviral agents.
    de Clercq E
    Acta Microbiol Acad Sci Hung; 1981; 28(3):289-306. PubMed ID: 6272552
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis.
    Cohen LS; Studzinski GP
    J Cell Physiol; 1967 Jun; 69(3):331-9. PubMed ID: 4230858
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the biosynthesis of thymidylic acid by 4-N-Hydroxy-2'-deoxycytidine in L5178Y leukemic cells.
    Nelson DJ; Carter CE
    Mol Pharmacol; 1966 May; 2(3):248-58. PubMed ID: 5962067
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell viability and nucleic acid metabolism after exposure of HeLa cells to excess thymidine and deoxyadenosine.
    Kim JH; Kim SH; Eidinoff ML
    Biochem Pharmacol; 1965 Dec; 14(12):1821-9. PubMed ID: 5880537
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative activity of 1-beta-d-arabinofuranosyl-5-fluorocytosine and related compounds against transplanted mouse leukemias in vivo and in vitro.
    Burchenal JH; Adams HH; Newell NS; Fox JJ
    Cancer Res; 1966 Mar; 26(3):370-3. PubMed ID: 5930685
    [No Abstract]   [Full Text] [Related]  

  • 9. Causes and conditions for the creation of nucleolar morphological changes with adenosine.
    Hroch M; Půza V
    Folia Morphol (Praha); 1970; 18(3):196-202. PubMed ID: 4194320
    [No Abstract]   [Full Text] [Related]  

  • 10. Human cytomegalovirus. Studies on the mechanism of viral cytopathology and inclusion body formation.
    McAllister RM; Filbert JE; Goodheart CR
    Proc Soc Exp Biol Med; 1967 Mar; 124(3):932-7. PubMed ID: 4290279
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA).
    Prince HN; Grunberg E; Buck M; Cleeland R
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1080-6. PubMed ID: 4305347
    [No Abstract]   [Full Text] [Related]  

  • 12. Nucleosides. 3. Studies on 5-methylamino-2'-deoxyuridine as a specific antiherpes agent.
    Shen TY; McPherson JF; Linn BO
    J Med Chem; 1966 May; 9(3):366-9. PubMed ID: 5960908
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymidine as a synchronizing agent. II. Partial recovery of HeLa cells from unbalanced growth.
    Lambert WC; Studzinski GP
    J Cell Physiol; 1969 Jun; 73(3):261-6. PubMed ID: 5783247
    [No Abstract]   [Full Text] [Related]  

  • 14. On the direct effect of cobalt on nucleic acid and protein metabolism in rat's bone marrow cultivated in vitro.
    Niebrój TK
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(3):294-7. PubMed ID: 4168606
    [No Abstract]   [Full Text] [Related]  

  • 15. ACTION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE ON THE NUCLEIC ACID METABOLISM AND VIABILITY OF HELA CELLS.
    KIM JH; EIDINOFF ML
    Cancer Res; 1965 Jun; 25():698-702. PubMed ID: 14347556
    [No Abstract]   [Full Text] [Related]  

  • 16. Arabinofuranosylcytosine-induced stimulation of thymidine kinase and deoxycytidylic deaminase activities of mammalian cultures.
    Kit S; De Torres RA; Dubbs DR
    Cancer Res; 1966 Sep; 26(9):1859-66. PubMed ID: 4958937
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymidine as a synchronizing agent. I. Nucleic acid and protein formation in synchronous HeLa cultures treated with excess thymidine.
    Studzinski GP; Lambert WC
    J Cell Physiol; 1969 Apr; 73(2):109-17. PubMed ID: 5789914
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
    Graham FL; Whitmore GF
    Cancer Res; 1970 Nov; 30(11):2636-44. PubMed ID: 5530558
    [No Abstract]   [Full Text] [Related]  

  • 20. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Dollinger MR; Burchenal JH; Kreis W; Fox JJ
    Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.